🇺🇸 CELLULOSE SODIUM PHOSPHATE in United States

FDA authorised CELLULOSE SODIUM PHOSPHATE on 28 December 1982

Marketing authorisations

FDA — authorised 28 December 1982

  • Application: NDA018757
  • Marketing authorisation holder: MISSION PHARMA
  • Local brand name: CALCIBIND
  • Indication: POWDER — ORAL
  • Status: approved

Read official source →

FDA

  • Status: approved

CELLULOSE SODIUM PHOSPHATE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is CELLULOSE SODIUM PHOSPHATE approved in United States?

Yes. FDA authorised it on 28 December 1982; FDA has authorised it.

Who is the marketing authorisation holder for CELLULOSE SODIUM PHOSPHATE in United States?

MISSION PHARMA holds the US marketing authorisation.